• Dr. Steven Kirkham

Adverum Biotechnologies is attempting approval of a single-dose gene therapy...

This gene therapy can express the drug aflibercept, used for treating macular degeneration, for up to 16 months, researchers reported in Molecular Therapy. This novel treatment—fast-tracked by the FDA earlier this year—is now undergoing a phase 1 trial in humans. Longer-lasting treatment for macular degeneration would solve the burdensome requirement in such patients of having repeated, sometimes monthly, injections of shorter-acting medications for long periods of time. Adverum Biotechnologies, Molecular Therapy

Marion Eye Center & Optical

1462 Marion Waldo Road

Marion, OH 43302

Tel. 740-389-5418

Fax. 740-389-5410

Office Hours

Monday - Friday:  9am - 5pm

(Delaware Office Closed Wednesdays)

  • Grey Facebook Icon
  • Grey Instagram Icon

© 2019 by Marion Eye Center

Website by Dalton Digital

Delaware Eye Center

241 Paddock Court

Delaware, OH 43015

Tel. 740-362-1100

Fax. 740-362-1911